National Institutes of Health · Federal agency

Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)

match

Award Up to $345k Deadline 1412 days ago Location Alabama Type grant Level Federal Closed posted Jul 7, 2022

This program is closed. The last application deadline was Oct 6, 2022.

We keep closed listings online for reference — agencies often reissue similar programs.

Still looking for funding? These related programs are open now:

Notice of Intent to Issue Notice of Funding Opportunity No. DE-FOA-0003442: Regional Direct Air Capture Hubs – Recurring Program — up to $1,400,000,000
ERDC Broad Agency Announcement — up to $999,999,999
ERDC Broad Agency Announcement — up to $999,999,999

Or browse every open program from National Institutes of Health.

✦ AI Summary

Who can apply: Federal-level applicants (see eligibility for details).
Funding amount: up to $345,000.
Next deadline: October 6, 2022.
Issued by: National Institutes of Health.

How was this generated?

The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.

AI-generated. Always verify with the official source.

Who can apply — at a glance

Eligible applicants: see the Eligibility tab for the criteria from the official announcement.
Where: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, District of Columbia.
Award: Up to $345k.
Matching funds: not required.
Deadline type: Fixed.

Compiled from the official listing's structured fields — always verify with the funder before applying.

About the funder

National Institutes of Health is a federal-level funder.

See all 1605 open programs from this agency →

Award amount

Up to $345k

Deadline

1412 days ago

Oct 6, 2022

About this opportunity

The National Institutes of Health (NIH) participating Institutes and Centers, in coordination with the Food and Drug Administration (FDA), seek highly meritorious clinical trial applications proposing to explore and enable the development of safe and effective regenerative medicine (RM) interventions using adult stem cells. This Funding Opportunity Announcement (FOA), issued as part of the Regenerative Medicine Innovation Project (RMIP), represents one step in fulfilling a statutory provision set forth in the 21st Century Cures Act. Applications submitted in response to this bi-phasic, milestone-driven cooperative agreement FOA are expected to propose highly innovative projects with a focus on solutions to widely-recognized issues in the development of safe and effective RM therapies. Of particular interest are projects using RM products that have undergone appropriate product development and pre-clinical studies and have demonstrated readiness to advance into clinical trials. This FOA seeks Phase I and beyond clinical trial applications that present a strong scientific rationale for the proposed clinical trial and a comprehensive scientific and operational plan. Trials must be relevant to the research mission of one or more participating NIH Institutes and Centers and meet the NIH definition of a clinical trial (see NOT-OD-15-015). Applications will be required to include plans for project management, participant recruitment and retention, performance milestones, conduct of the trial, and dissemination of results. Before the time of award and if applicable, successful applicants must obtain an Investigational New Drug (IND) authorization or Investigational New Device Exemption (IDE) approval to administer the product to humans.

Funding agency

National Institutes of Health

Federal agency

Who can apply

Eligibility details aren't on file yet — check the agency source link in the Documents tab for the latest rules.

Geographic eligibility

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
District of Columbia

How to apply

We don't have application instructions on file yet — head straight to the official source.

Apply on agency site

Tip from our team:

Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.

Need help getting in touch with the right agency contact?

Create a free account and our specialists will guide you through the application end-to-end.

Source documents

View on agency site

Canonical NOFO, application packet, and forms

No supplemental documents yet.

Direct downloads (NOFO PDFs, application forms, FAQs) will appear here once our team attaches them. For now, the agency site has the canonical packet.

Citation details

Source systemgrants.gov

Source ID341946

PostedJul 7, 2022

Frequently asked questions

No FAQs yet.

Have a question about this fund? Sign in to open a ticket about this fund.

Apply on agency site Save & get email alerts

Free account — we'll email you about deadline changes, status updates, and award revisions for this grant. Already registered? Sign in

match

Match score

Estimated based on this fund's profile

Award size Up to $345k

Deadline 1412 days ago

Level Federal

Type grant

Apply on agency site